Coronary Intravascular Lithotripsy Market to Hit USD 648.5 million by 2035 Driven by Innovation & Adoption

The global coronary intravascular lithotripsy (IVL) market is entering a pivotal growth phase, with projections showing a rise from USD 365.9 million in 2025 to USD 648.5 million by 2035. Registering a compound annual growth rate of 5.9%, this expansion reflects the growing clinical reliance on IVL as a minimally invasive and highly effective treatment for calcified coronary artery disease. Both established multinational corporations and new entrants are investing in advanced technologies and expanding their presence in new geographies, aiming to capture the surging demand for safer, more efficient cardiovascular procedures.

The Rise of Intravascular Lithotripsy in Cardiovascular Care

The increasing prevalence of cardiovascular diseases, particularly those involving calcified coronary artery conditions, is driving demand for novel interventional therapies. Intravascular lithotripsy has emerged as a breakthrough option, offering precision in modifying calcified plaque, improving stent placement, and ensuring long-term vessel patency. Unlike traditional therapies, IVL enhances procedural safety, reduces complications, and ensures quicker recovery for patients.

Full Market Report available for delivery. For purchase or customization, please request here: https://www.futuremarketinsights.com/reports/sample/rep-gb-17677

Hospitals, which account for 38.6% of the market in 2025, are at the forefront of adoption. Their infrastructure, access to specialized cardiac catheterization labs, and the expertise of interventional cardiologists make them the natural leaders in expanding IVL usage. As more clinical data validates the long-term benefits of the technology, the hospital segment is expected to grow steadily, driven by improved patient outcomes and operational efficiencies.

Comparing Historical Progress with Future Potential

Between 2020 and 2025, the coronary intravascular lithotripsy market grew at a CAGR of 5.0%, reaching USD 365.9 million. This period marked the transition of IVL from a new interventional option to an increasingly accepted treatment backed by growing physician experience and expanding clinical evidence.

Looking ahead, the market is forecast to accelerate with a CAGR of 6.2% from 2025 to 2035, reaching USD 648.5 million. This upward trajectory reflects increasing physician acceptance, technological advancements in catheter design and energy delivery, and supportive reimbursement policies across key markets. As minimally invasive procedures become standard in cardiology, IVL is positioned to be a central technology in the treatment of complex coronary lesions.

Global Market Highlights

The United States remains the single largest market, projected to reach USD 648.5 million by 2035 at a CAGR of 6.6%. The country's high prevalence of coronary artery disease, combined with robust healthcare infrastructure, provides fertile ground for rapid adoption. According to the CDC, coronary heart disease killed over 375,000 individuals in 2024, highlighting the urgent need for advanced interventions like IVL.

In Europe, the United Kingdom is expected to expand to USD 28.0 million by 2035 at a CAGR of 6.1%, supported by the NHS's significant annual investments in medical technologies. The government's push for minimally invasive treatments aligns with IVL adoption, enhancing patient access to novel therapies.

Asia-Pacific is emerging as a key growth hub. China, with its rapidly expanding healthcare infrastructure and preference for minimally invasive procedures, is forecast to reach USD 48.4 million by 2035, growing at 8.8% CAGR. Japan is set to reach USD 21.9 million by 2035, aided by an aging population and favorable regulatory support, while South Korea is expected to hit USD 7.2 million by 2035, thanks to strong government initiatives promoting advanced cardiac care.

Hospitals at the Core of Market Expansion

Hospitals represent the backbone of the IVL market, commanding 42.7% of the share in 2025 and projected to grow at 7.3% CAGR through 2035. Their dominance stems from the ability to integrate IVL into comprehensive cardiovascular programs, ensuring standardized care and post-procedural monitoring. By offering cutting-edge treatments like IVL, hospitals not only improve patient care but also strengthen their role as referral centers for advanced cardiology.

Established Leaders and Emerging Innovators

The competitive landscape is highly dynamic, with established players like Abbott, Siemens, Boston Scientific Corporation, Olympus America, and Cardiovascular Systems Inc. shaping the industry's growth trajectory. These companies are leveraging product innovation, clinical trials, and global distribution networks to expand their leadership.

One of the most notable developments came in February 2024, when Shockwave Medical, Inc. secured FDA approval for its Shockwave IVL System and the Shockwave C2 Coronary IVL Catheter in the United States. This milestone underscores the growing regulatory acceptance of IVL and cements Shockwave's role as a leading innovator in the space.

Emerging players, meanwhile, are exploring new catheter designs, energy delivery systems, and hybrid technologies that integrate IVL with other interventional tools. Startups and regional manufacturers are increasingly focused on localizing production in markets like China and India, ensuring cost competitiveness and broader access.

Request Market Research Draft Report: https://www.futuremarketinsights.com/reports/coronary-intravascular-lithotripsy-market

Strategies Shaping the Future

Product innovation remains the primary growth driver, with companies investing heavily in research and development to improve the efficiency, precision, and affordability of IVL systems. At the same time, strategic collaborations and partnerships are expanding global market reach. Leading firms are aligning with hospitals, research institutions, and technology companies to accelerate adoption and clinical validation.

Expansion into emerging markets is another key priority. By strengthening local manufacturing and distribution networks in Asia-Pacific and Latin America, manufacturers are unlocking opportunities in fast-growing healthcare ecosystems. Mergers and acquisitions are also frequent, allowing larger firms to consolidate their positions, broaden product portfolios, and gain access to untapped regions.

Patient-Centered Benefits Driving Adoption

The success of IVL goes beyond technological innovation. Its ability to provide minimally invasive, safe, and reliable treatment aligns with the growing demand for patient-centered healthcare. IVL reduces the risks associated with traditional interventions, ensures faster recovery times, and allows elderly and high-risk patients to undergo treatment with fewer complications.

As the global population ages and cardiovascular diseases become increasingly common, demand for technologies like IVL will continue to grow. The alignment of patient needs, clinical outcomes, and technological advancements ensures that IVL will remain a cornerstone of interventional cardiology for years to come.

Related Reports:

Gel Implants Market: https://www.futuremarketinsights.com/reports/gel-implants-market

INR Test Meter Market: https://www.futuremarketinsights.com/reports/inr-test-meter-market

Phakic Intraocular Lenses (IOL) Market: https://www.futuremarketinsights.com/reports/phakic-intraocular-lenses-iol-market

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

This release was published on openPR.